APOE genetic associations with seizure development after severe traumatic brain injury

Brain Injury

Volumn 24, Issue 12, 2010, Pages 1468-1477

  Miller, Megan A ^a   Conley, Yvette ^b,c   Scanlon, Joelle M ^a   Ren, Dianxu ^c   Ilyas Kamboh, M ^c   Niyonkuru, Christian ^a   Wagner, Amy K ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

APOE; Genetic susceptibility; Post traumatic seizures; Traumatic brain injury

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; POSTTRAUMATIC COMPLICATION; POSTTRAUMATIC SEIZURE; SEIZURE; TRAUMATIC BRAIN INJURY;

EID: 77958505929     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699052.2010.520299     Document Type: Article

References (58)

1. Hyder AA, Wunderlich CA, Puvanachandra P, Gururaj G, Kobusingye OC. The impact of traumatic brain injuries: A global perspective. Neurorehabilitation 2007;22:341-353.
2. Rutland-Brown W, Langlois JA, Thomas KE, Xi YL. Incidence of traumatic brain injury in the United States, 2003. Journal of Head Trauma Rehabilitation 2006;21: 544-548.
3. Bhattacharjee Y. Neuroscience. Shell shock revisited: Solving the puzzle of blast trauma. Science 2008;319:406-408.
4. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991;32:429-445.
5. Bushnik T, Englander J, Duong T. Medical and social issues related to posttraumatic seizures in persons with traumatic brain injury. Journal of Head Trauma Rehabilitation 2004;19:296-304.
6. Vespa PM, Nuwer MR, Nenov V, Ronne-Engstrom E, Hovda DA, Bergsneider M, Kelly DF, Martin NA, Becker DP. Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. Journal of Neurosurgery 1999;91:750-760.
7. Haltiner AM, Temkin NR, Dikmen SS. Risk of seizure recurrence after the first late posttraumatic seizure. Archives of Physical Medicine & Rehabilitation 1997;78:835-840.
8. Asikainen I, Kaste M, Sarna S, Asikainen I, Kaste M, Sarna S. Early and late posttraumatic seizures in traumatic brain injury rehabilitation patients: Brain injury factors causing late seizures and influence of seizures on long-term outcome. Epilepsia 1999;40:584-589.
9. Englander J, Bushnik T, Wright JM, Jamison L, Duong TT, Englander J, Bushnik T, Wright JM, Jamison L, Duong TT. Mortality in late post-traumatic seizures. Journal of Neurotrauma 2009;26:1471-1477.
10. Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. New England Journal of Medicine 1990;323:497-502.
11. Young B, Ott L, Twyman D, Norton J, Rapp R, Tibbs P, Haack D, Brivins B, Dempsey R. The effect of nutritional support on outcome from severe head injury. Journal of Neurosurgery 1987;67:668-676. (Pubitemid 17161395)
12. Temkin NRE, Temkin NR. Preventing and treating post-traumatic seizures: The human experience. Epilepsia 2009; 50:10-13.
13. Dikmen SS, Temkin NR, Miller B, Machamer J, Winn HR. Neurobehavioral effects of phenytoin prophylaxis of post-traumatic seizures. JAMA: The Journal of the American Medical Association 1991;265:1271-1277.
14. Smith Jr KR, Goulding . PM, Wilderman D, Goldfader PR, Holterman-Hommes P, Wei F. Neurobehavioral effects of phenytoin and carbamazepine in patients recovering from brain trauma: A comparative study. Archives of Neurology 1994;51:653-660.
15. Mohler LM, Cummings E, Darrah SH, Chen XC, Galang G, Chuang J, Wagner AK. Cognitive and behavioral effects of dilantin administration after controlled cortical impact. Journal of Neurotrauma 2008;25:874.
16. Annegers JF, Hauser WA, Coan SP, Rocca WA. A population-based study of seizures after traumatic brain injuries. New England Journal of Medicine 1998;338:20-24.
17. Temkin NR. Risk factors for posttraumatic seizures in adults. Epilepsia 2003;44(Suppl 10):18-20.
18. Cavalleri GL, Weale ME, Shianna KV, Singh R, Lynch JM, Grinton B, Szoeke C, Murphy K, Kinirons P, O'Rourke D, et al. Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: A case-control study. Lancet Neurology 2007;6:970-980.
19. Hung CC, Tai JJ, Lin CJ, Lee MJ, Liou HH. Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response. Pharmacogenomics 2005;6:411-417.
20. Chu AY, Parekh RS, Astor BC, Coresh J, Berthier-Schaad Y, Smith MW, Shuldiner AR, Kao WH. Association of APOE polymorphism with chronic kidney disease in a nationally representative sample: A Third National Health and Nutrition Examination Survey (NHANES III) Genetic Study. BMC Medical Genetics 2009;10:108.
21. Chen Y, Lomnitski L, Michaelson DM, Shohami E, Chen Y, Lomnitski L, Michaelson DM, Shohami E. Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience 1997;80:1255-1262. (Pubitemid 27359807)
22. Nathoo N. Genetic vulnerability following traumatic brain injury: The role of apolipoprotein E. Molecular Pathology 2003;56:132-136.
23. Friedman G, Froom P, Sazbon L, Grinblatt I, Shochina M, Tsenter J, Babaey S, Yehuda B, Groswasser Z, Friedman G, et al. Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 1999;52:244-248.
24. Lichtman SW, Seliger G, Tycko B, Marder K, Lichtman SW, Seliger G, Tycko B, Marder K. Apolipoprotein E and functional recovery from brain injury following postacute rehabilitation. Neurology 2000;55:1536-1539.
25. Teasdale GM, Nicoll JA, Murray G, Fiddes M, Teasdale GM, Nicoll JA, Murray G, Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 1997;350:1069-1071. (Pubitemid 27437858)
26. Zhou W, Xu D, Peng X, Zhang Q, Jia J, Crutcher KA. Meta-analysis of APOE4 allele and outcome after traumatic brain injury. Journal of Neurotrauma 2008;25:279-290.
27. Alexander S, Kerr ME, Kim Y, Kamboh MI, Beers SR, Conley YP. Apolipoprotein E4 allele presence and functional outcome after severe traumatic brain injury. Journal of Neurotrauma 2007;24:790-797.
28. Teasdale GM, Murray GD, Nicoll JA. The association between APOE epsilon4, age and outcome after head injury: A prospective cohort study. Brain 2005;128: 2556-2561.
29. Briellmann RS, Torn-Broers Y, Busuttil BE, Major BJ, Kalnins RM, Olsen M, Jackson GD, Frauman AG, Berkovic SF. APOE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology 2000;55:435-437.
30. Diaz-Arrastia R, Gong Y, Fair S, Scott KD, Garcia MC, Carlile MC, Agostini MA, Van Ness PC. Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele. Archives of Neurology 2003;60: 818-822.
31. Anderson GD, Temkin NR, Dikmen SS, Diaz-Arrastia R, Machamer JE, Farhrenbruch C, Miller JW, Sadrzadeh SM. Haptoglobin phenotype and apolipoprotein E polymorphism: Relationship to posttraumatic seizures and neuropsycholog-ical functioning after traumatic brain injury. Epilepsy and Behaviour 2009;16:501-506.
32. Bullock R, Chesnut RM, Clifton G, Ghajar J, Marion DW, Narayan RK, Newell DW, Pitts LH, Rosner MJ, Wilberger JW. Guidelines for the management of severe head injury. Brain Trauma Foundation. European Journal of Emergency Medicine 1996;3:109-127.
33. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480-484.
34. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 1988;16:1215.
35. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. Journal of Lipid Research 1990;31:545-548.
36. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST. APOE E4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. Nature Genetics 1995;10:486-488, [Erratum appears in Nature Genetics 1995;11:104].
37. Johnson VE, Stewart W, Stewart JE, Graham DI, Praestgaard AH, Smith DH. A neprilysin polymorphism and amyloidbeta plaques following traumatic brain injury. Journal of Neurotrauma 2009;26:1197-1202.
38. Kay AD, Petzold A, Kerr M, Keir G, Thompson E, Nicoll JA. Alterations in cerebrospinal fluid apolipoprotein E and amyloid beta-protein after traumatic brain injury. Journal of Neurotrauma 2003;20:943-952. (Pubitemid 37288554)
39. Horsburgh K, McCarron MO, White F, Nicoll JA. The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: Evidence of common mechanisms and utility of animal models. Neurobiology of Aging 2000;21:245-255.
40. White JR, Farukhi Z, Bull C, Christensen J, Gordon T, Paidas C, Nichols DG. Predictors of outcome in severely head-injured children. Critical Care Medicine 2001;29: 534-540.
41. Holtzman DM, Bales KR, Wu S, Bhat P, Parsadanian M, Fagan AM, Chang LK, Sun Y, Paul SM. Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. Journal of Clinical Investigation 1999;103:R15-R21.
42. Nicoll JA, Roberts GW, Graham DI, Nicoll JA, Roberts GW, Graham DI. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nature Medicine 1995;1:135-137.
43. Martel CL, Mackic JB, Matsubara E, Governale S, Miguel C, Miao W, McComb JG, Frangione B, Ghiso J, Zlokovic BV. Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta. Journal of Neurochemistry 1997;69:1995-2004.
44. Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, Holtzman DM, Zlokovic BV. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. Journal of Clinical Investigation 2008;118:4002-4013.
45. Gouras GK, Relkin NR, Sweeney D, Munoz DG, Mackenzie IR, Gandy S. Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques. Annals of Neurology 1997;41:402-404.
46. Mackenzie IR, Miller LA. Senile plaques in temporal lobe epilepsy. Acta Neuropathologica 1994;87:504-510.
47. Blumcke I, Brockhaus A, Scheiwe C, Rollbrocker B, Wolf HK, Elger CE, Wiestler OD. The apolipoprotein E epsilon 4 allele is not associated with early onset temporal lobe epilepsy. Neuroreport 1997;8:1235-1237.
48. Gambardella A, Aguglia U, Cittadella R, Romeo N, Sibilia G, LePiane E, Messina D, Manna I, Oliveri RL, Zappia M, et al. Apolipoprotein E polymorphisms and the risk of nonlesional temporal lobe epilepsy. Epilepsia 1999;40: 1804-1807.
49. Angeleri F, Majkowski J, Cacchio G, Sobieszek A, D'Acunto S, Gesuita R, Bachleda A, Polonara G, Krolicki L, Signorino M, et al. Posttraumatic epilepsy risk factors: One-year prospective study after head injury. Epilepsia 1999;40:1222-1230.
50. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer's disease. Annual Review of Neuroscience 1996;19:53-77.
51. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell Jr PC, Rimmler . JB, Locke PA, Conneally PM, Schmader KE. Protective effect of apolipo-protein E type 2 allele for late onset Alzheimer disease. Nature Genetics 1994;7:180-184.
52. Hayes GM. Severe seizures associated with traumatic brain injury managed by controlled hypothermia, pharmacologic coma, and mechanical ventilation in a dog. Journal of Veterinary Emergency and Critical Care (San Antonio) 2009;19:629-634.
53. Clark RS, Kochanek PM, Marion DW, Schiding JK, White M, Palmer AM, DeKosky ST. Mild posttraumatic hypothermia reduces mortality after severe controlled cortical impact in rats. Journal of Cerebral Blood Flow & Metabolism 1996;16:253-261.
54. Wagner AK, Miller MA, Scanlon J, Ren D, Kochanek PM, Conley YP. Adenosine A1 receptor gene variants associated with post-traumatic seizures after severe TBI. 2010;90: 259-272.
55. Wagner AK, Fabio A, Puccio AM, Hirschberg R, Li W, Zafonte RD, Marion DW. Gender associations with cere-brospinal fluid glutamate and lactate/pyruvate levels after severe traumatic brain injury. Critical Care Medicine 2005;33:407-413.
56. Lin CM, Lin JW, Chen YC, Shen HH, Wei L, Yeh YS, Chiang YH, Shih R, Chiu PL, Hung KS, et al. Hyaluronic acid inhibits the glial scar formation after brain damage with tissue loss in rats. Surgical Neurologu 2009;72(Suppl 2): S50-S54.
57. Chen XH, Johnson VE, Uryu K, Trojanowski JQ, Smith DH. A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury. Brain Pathology 2009;19:214-223.
58. Rocchi A, Orsucci D, Tognoni G, Ceravolo R, Siciliano G. The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects. Current Alzheimer Research 2009;6:224-237.